Regeneron Pharmaceuticals won $406.8 million in damages for a lawsuit claiming Amgen violated antitrust and tort laws. A jury in a Delaware court found that Amgen violated certain laws, and gave ...

Shares of Regeneron Pharmaceuticals Inc. REGN advanced 2.39% to $584.99 Thursday, on what proved to be an all-around positive ...

Fintel reports that on May 14, 2025, Citigroup upgraded their outlook for Regeneron Pharmaceuticals (NasdaqGS:REGN) from ...

Explore Regeneron Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for REGN. Sanofi plans $20 billion US investment by 2030 to expand R&D and ...

Leading life science executives, government officials, academic leaders, and investors gather for two day off-the-record ...

Representative Robert Bresnahan Jr. recently waved goodbye to his Regeneron Pharmaceuticals shares, sparking curiosity over ...

Trusted by 150+ million investors each month, your ideas have shaped the most popular finance destination.¹ Explore what you can do with news, data, and tools designed to help you make financial ...

However, throughout this time, it faced issues like lawsuits and power struggles, causing a loss of investor trust ... suggesting weak buying interest. If $0.637 support fails, further downside is ...

All eyes have been on Bitcoin since it broke through the $100,000 barrier and vaulted to an even higher ATH – and its impressive performance in the face of Donald Trump’s constantly shifting tariff ...

AvaxMinerAI is an AI-driven meme coin on Avalanche. It hit a new all-time high on January 6th, showing great investor interest and market activity. AvaxMinerAI has a market cap of $448,371 and a ...

Bulls need more than headlines — they need follow-through. This delivery report was NIO’s best in months. But can it hold investor interest? That’s the real test now. Without stronger production ...